Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients – the Tromsø Study
Trygve S. Ellingsen,
Jostein Lappegård,
Tove Skjelbakken,
Sigrid K. Brækkan,
John-Bjarne Hansen
Affiliations
Trygve S. Ellingsen
K.G. Jebsen Thrombosis Research and Expertise Center, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway;Hematological Research Group, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway
Jostein Lappegård
K.G. Jebsen Thrombosis Research and Expertise Center, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway;Hematological Research Group, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway
Tove Skjelbakken
K.G. Jebsen Thrombosis Research and Expertise Center, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway;Hematological Research Group, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway;Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
Sigrid K. Brækkan
K.G. Jebsen Thrombosis Research and Expertise Center, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway;Hematological Research Group, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway;Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
John-Bjarne Hansen
K.G. Jebsen Thrombosis Research and Expertise Center, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway;Hematological Research Group, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway;Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
